Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: Protocol summary and interim report

Sattva S. Neelapu, Barry L. Gause, Daniel A. Nikcevich, Stephen J. Schuster, Jane Winter, Jon P. Gockerman, Thomas Loughran, Ken Takeshita, Giorgio Inghirami, Dean McGaughey, Thelma M. Watson, Sandra Snow, Paula Kubovic, Miriam Ferraro, Elizabeth Jones, Elaine S. Jaffe, Douglas J. Schwartzentruber, David Danforth, Richard Sherry, Erik KassCarter Van Waes, Craig W. Reynolds, Larry W. Kwak*

*Corresponding author for this work

Research output: Contribution to journalArticle

23 Scopus citations
Original languageEnglish (US)
Pages (from-to)61-64
Number of pages4
JournalClinical Lymphoma
Volume6
Issue number1
DOIs
StatePublished - Jun 2005

Keywords

  • B-cell lymphoma
  • Hybridoma
  • Id-keyhole limpet hemocyanin
  • PACE chemotherapy

ASJC Scopus subject areas

  • Cancer Research

Cite this

Neelapu, S. S., Gause, B. L., Nikcevich, D. A., Schuster, S. J., Winter, J., Gockerman, J. P., Loughran, T., Takeshita, K., Inghirami, G., McGaughey, D., Watson, T. M., Snow, S., Kubovic, P., Ferraro, M., Jones, E., Jaffe, E. S., Schwartzentruber, D. J., Danforth, D., Sherry, R., ... Kwak, L. W. (2005). Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: Protocol summary and interim report. Clinical Lymphoma, 6(1), 61-64. https://doi.org/10.3816/CLM.2005.n.031